Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy
- Author
- Lea Olive Tchouate Gainkam, Marleen Keyaerts, Vicky Caveliers, Nick Devoogdt, Christian Vanhove (UGent) , Leo Van Grunsven, Serge Muylderman and Tony Lahoutte
- Organization
- Keywords
- WILD-TYPE, RENAL UPTAKE, MICE, EXPRESSION, MUTATIONS, GEFITINIB, Epidermal growth factor receptor (EGFR), Cetuximab, Erlotinib, (99m)Tc-7C12-nanobody, Specificity, Therapy monitoring, Bioluminescence imaging, IN-VIVO, ANTI-EGFR NANOBODIES, PINHOLE SPECT/MICRO-CT, CELL LUNG-CANCER
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 350.72 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-2118656
- MLA
- Gainkam, Lea Olive Tchouate, et al. “Correlation between Epidermal Growth Factor Receptor-Specific Nanobody Uptake and Tumor Burden: A Tool for Noninvasive Monitoring of Tumor Response to Therapy.” MOLECULAR IMAGING AND BIOLOGY, vol. 13, no. 5, 2011, pp. 940–48, doi:10.1007/s11307-010-0428-4.
- APA
- Gainkam, L. O. T., Keyaerts, M., Caveliers, V., Devoogdt, N., Vanhove, C., Van Grunsven, L., … Lahoutte, T. (2011). Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy. MOLECULAR IMAGING AND BIOLOGY, 13(5), 940–948. https://doi.org/10.1007/s11307-010-0428-4
- Chicago author-date
- Gainkam, Lea Olive Tchouate, Marleen Keyaerts, Vicky Caveliers, Nick Devoogdt, Christian Vanhove, Leo Van Grunsven, Serge Muylderman, and Tony Lahoutte. 2011. “Correlation between Epidermal Growth Factor Receptor-Specific Nanobody Uptake and Tumor Burden: A Tool for Noninvasive Monitoring of Tumor Response to Therapy.” MOLECULAR IMAGING AND BIOLOGY 13 (5): 940–48. https://doi.org/10.1007/s11307-010-0428-4.
- Chicago author-date (all authors)
- Gainkam, Lea Olive Tchouate, Marleen Keyaerts, Vicky Caveliers, Nick Devoogdt, Christian Vanhove, Leo Van Grunsven, Serge Muylderman, and Tony Lahoutte. 2011. “Correlation between Epidermal Growth Factor Receptor-Specific Nanobody Uptake and Tumor Burden: A Tool for Noninvasive Monitoring of Tumor Response to Therapy.” MOLECULAR IMAGING AND BIOLOGY 13 (5): 940–948. doi:10.1007/s11307-010-0428-4.
- Vancouver
- 1.Gainkam LOT, Keyaerts M, Caveliers V, Devoogdt N, Vanhove C, Van Grunsven L, et al. Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy. MOLECULAR IMAGING AND BIOLOGY. 2011;13(5):940–8.
- IEEE
- [1]L. O. T. Gainkam et al., “Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy,” MOLECULAR IMAGING AND BIOLOGY, vol. 13, no. 5, pp. 940–948, 2011.
@article{2118656,
author = {{Gainkam, Lea Olive Tchouate and Keyaerts, Marleen and Caveliers, Vicky and Devoogdt, Nick and Vanhove, Christian and Van Grunsven, Leo and Muylderman, Serge and Lahoutte, Tony}},
issn = {{1536-1632}},
journal = {{MOLECULAR IMAGING AND BIOLOGY}},
keywords = {{WILD-TYPE,RENAL UPTAKE,MICE,EXPRESSION,MUTATIONS,GEFITINIB,Epidermal growth factor receptor (EGFR),Cetuximab,Erlotinib,(99m)Tc-7C12-nanobody,Specificity,Therapy monitoring,Bioluminescence imaging,IN-VIVO,ANTI-EGFR NANOBODIES,PINHOLE SPECT/MICRO-CT,CELL LUNG-CANCER}},
language = {{eng}},
number = {{5}},
pages = {{940--948}},
title = {{Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy}},
url = {{http://dx.doi.org/10.1007/s11307-010-0428-4}},
volume = {{13}},
year = {{2011}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: